You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 6, June 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Production of Lymphokine-Activated Lymphocytes

Lysis of Human Head and Neck Squamous Cell Carcinoma Cell Lines

David M. Alessi, MD; Robert W. Hutcherson, MD; Robert A. Mickel, MD, PhD

Arch Otolaryngol Head Neck Surg. 1989;115(6):725-730.


Abstract

• Lymphokine-activated killer cells are thought to be important mediators of host tumor defense. In the present study, the cytotoxic potential of lymphokine-activated lymphocytes against different head and neck squamous cell carcinoma cell lines was investigated. Lymphokine-activated killer cells were derived from peripheral blood lymphocytes. Effector peripheral blood lymphocyte cell suspensions were incubated in the presence or absence of recombinant interleukin-2. Cytotoxicity of incubated cells or fresh peripheral blood lymphocytes was determined in a 3-hour chromium 51 release assay. Target cell lines included K562 (a natural killer–sensitive target) and the following head and neck squamous cell carcinoma cell lines: Cal 27, UMSCC-1, UMSCC-8, UMSCC-16, UMSCC-19, and UMSCC-22a. Fresh peripheral blood lymphocytes and peripheral blood lympho



Author Affiliations

From the Division of Head and Neck Surgery, UCLA School of Medicine (Drs Alessi, Hutcherson, and Mickel) and West Los Angeles Veterans Administration Medical Center (Dr Mickel), Jonnson Comprehensive Cancer Center (Dr Mickel), and West Los Angeles Veterans Administration Medical Center Cancer Center (Dr Mickel), Los Angeles, Calif.


Footnotes

Accepted for publication December 20, 1988.

Read in part at the Midwinter Meeting of the Association for Research in Otolaryngology, Clearwater, Fla, February 3, 1988.

Reprint requests to Division of Head and Neck Surgery (W112C), West Los Angeles Veterans Administration Medical Center, Wilshire and Sawtelle boulevards, Los Angeles, CA 90073 (Dr Mickel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Inhibition of Lymphocyte Function by Head and Neck Carcinoma Cell Line Soluble Factors
Bailet et al.
Arch Otolaryngol Head Neck Surg 1997;123:855-862.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.